Objective: The metabolic syndrome is associated with increased risk for cardiovascular disease and diabetes. Several analyses from the Atherosclerosis Risk in Communities (ARIC) study have been performed to examine the role of the metabolic syndrome and its components in predicting risk for cardiovascular disease and diabetes. Design and subjects: The large, biracial, population-based ARIC study enrolled 15 792 middle-aged Americans in four communities in the United States and has followed them for the development of cardiovascular disease and diabetes. Measurements: Outcome parameters included prevalence of the metabolic syndrome and its individual components, carotid intima-media thickness, incident coronary heart disease, incident ischemic stroke and incident diabetes. Results and conclusion: Several analyses from the ARIC study have shown that the metabolic syndrome, as well as individual metabolic syndrome components, is predictive of the prevalence and incidence of coronary heart disease, ischemic stroke, carotid artery disease and diabetes.
Introduction
The metabolic syndrome has been shown to increase risk for cardiovascular disease (CVD) and diabetes and was established as a secondary target of therapy in the Adult Treatment Panel III (ATP III) guidelines of the US National Cholesterol Education Program. 1 According to the ATP III definition, the metabolic syndrome is diagnosed by the presence of three or more of the following characteristics: waist circumference 440 inches (102 cm) in men, 435 inches (88 cm) in women; triglycerides X107 mmol l
À1
; highdensity lipoprotein cholesterol (HDL-C) o100 mmol l À1 in men, o103 mmol l À1 in women; blood pressure X130/ X85 mm Hg; and fasting glucose 601-609 mmol l
. 2 Data from the US National Health and Nutrition Examination Survey indicate that age-adjusted prevalence of the metabolic syndrome, as defined by the ATP III guidelines, is 27% in adults and has been increasing. 3 The role of the metabolic syndrome and its individual components in predicting risk for CVD and diabetes has been examined in the Atherosclerosis Risk in Communities (ARIC) study, a large, prospective, biracial cohort study of cardiovascular risk factors in 15 792 middle-aged (aged 45-64 years) Americans. 4 Analyses have evaluated the influence of the metabolic syndrome on both prevalence and incidence of CVD as well as on the prediction of diabetes.
Metabolic syndrome and prevalence of CVD
In a cross-sectional analysis of 14 502 ARIC participants, using data from 1987 to 1989, prevalence of the metabolic syndrome as defined by ATP III was 30%, with considerable variation across subgroups defined by sex and race. 5 The highest metabolic syndrome prevalence was in black women (38%), and the lowest was in black men (26%); 31% of white men and 28% of white women had the metabolic syndrome.
After adjustment for age, ARIC center, low-density lipoprotein cholesterol (LDL-C) level and smoking status, ARIC participants who had the metabolic syndrome were two times more likely to have prevalent coronary heart disease (CHD; defined as prior myocardial infarction or cardiovascular revascularization) than participants without the metabolic syndrome. 5 For each subgroup defined by sex and race, prevalence of CHD (without this adjustment) was significantly higher in individuals with than in individuals without the metabolic syndrome, the highest CHD prevalence being in white men with the metabolic syndrome (13%, compared with 7% in white men without the metabolic syndrome). Among participants with the metabolic syndrome in other subgroups, CHD prevalence was 11% in black men (compared with 4% in black men without the metabolic syndrome), 4% in black women (compared with 2% in black women without the metabolic syndrome) and 3% in white women (compared with 1% in white women without the metabolic syndrome).
The extent of carotid artery atherosclerosis, assessed by intima-media thickness (IMT) determined by B-mode ultrasound, was also significantly greater in ARIC participants with the metabolic syndrome. 5 Mean IMT for six segments (carotid bifurcation, common carotid and internal carotid in left and right carotid arteries) was 747 mm in individuals with and 704 mm in individuals without the metabolic syndrome. After adjustment for age, ARIC center, LDL-C level, smoking status, lipoprotein(a) level and white blood cell count, IMT in individuals with the metabolic syndrome was 38 mm greater in both white men and white women, 29 mm greater in black women and 27 mm in black men compared with the corresponding subgroups without the metabolic syndrome.
Metabolic syndrome and incidence of CVD
The incidence of CHD and ischemic stroke over a mean 11-year follow-up was also assessed in ARIC participants with and without the metabolic syndrome. In this analysis of data from 12 089 individuals without diabetes, CHD or stroke at baseline, prevalence of the metabolic syndrome as defined by ATP III was 23%. 6 Incident CHD was defined as fatal or nonfatal CHD, silent myocardial infarction identified by electrocardiography or coronary revascularization. The crude incidence rate of CHD per 10 000 person-years was significantly higher in both men and women with the metabolic syndrome (138.4 and 57. (Figure 1 ). Applying the lower threshold for impaired fasting glucose (506 mmol l À1 ) 7 to the metabolic syndrome did not change the magnitude of observed associations between the metabolic syndrome and either CHD or stroke estimated from the original ATP III definition. In multivariable-adjusted models that included all individual components of the metabolic syndrome, risk for CHD associated with the presence of the metabolic syndrome was not in excess of the risk explained by its individual components. Also, a comparison of receiver operating characteristic curves (ROC curves) estimated from logistic regression indicated that identification of the metabolic syndrome did not improve CHD risk prediction beyond the Framingham risk score. The crude incidence rate of ischemic stroke per 10 000 person-years was also significantly higher in ARIC participants with the metabolic syndrome (24.6 in men and 19.0 in women, versus 18.1 and 8.5 in men and women, respectively, without the metabolic syndrome). After adjustment for age, race/ARIC center, LDL-C level and smoking status, the HR for incident ischemic stroke in ARIC participants with versus without the metabolic syndrome was 1.42 (95% CI: 0.96-2.11) in men and 1.96 (95% CI: 1.28-3.00) in women.
Metabolic syndrome and prediction of diabetes
In addition to increasing risk for CVD, the metabolic syndrome increases risk for diabetes. In an analysis of 7915 ARIC participants without diabetes at baseline, panels of risk factors and the presence of the metabolic syndrome were assessed for their predictivity for incident diabetes over 9 years of follow-up ( Figure 2) . 8 For the risk factor panels, models that included fasting glucose, triglycerides and HDL-C in addition to clinical variables (sex, ethnicity, parental history of diabetes, systolic blood pressure, waist and height; area under the ROC curve (AUC) ¼ 0.80, 95% CI: 0.78-0.82) were significantly better for predicting incident diabetes than clinical variables alone (AUC ¼ 0.71, 95% CI: 0.69-0.73). However, in a model that assigned 1 point for each criterion of the metabolic syndrome and additional points for obesity and elevated fasting glucose, a score of 3 or more labeled 46% of participants as high risk and identified 81% of future cases of diabetes (AUC ¼ 0.78, 95% CI: 0.76-0.80). The investigators concluded that rules based on the metabolic syndrome, which may be easier to apply in clinical settings, although slightly less predictive, are valid alternatives to more complex and complete risk function equations. In a similar investigation evaluating strategies to detect prevalent diabetes not diagnosed by fasting glucose, ARIC investigators evaluated the use of the metabolic syndrome to detect individuals classified as having diabetes by a 2-h glucose value X1101 mmol l À1 during a 75-g oral glucose tolerance test. The presence of three or more ATP III-defined metabolic syndrome abnormalities, while labeling 28% of the sample as positive, identified 40% of individuals with undetected diabetes with a specificity of 72%. By comparison, a clinical prediction rule composed of clinical findings, fasting glucose, HDL-C and triglycerides, while labeling 30% of the sample as positive, identified 56% of individuals with undetected diabetes with a specificity of 71%.
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Summary
The metabolic syndrome is associated with prevalence and incidence of CHD, stroke and increased carotid IMT in middle-aged Americans. Although the prediction of incident CHD was not better than with the Framingham risk score, most physicians in clinical practice do not use the Framingham risk score. 10 Furthermore, the metabolic syndrome was also highly predictive for development of diabetes. Thus, the simple clinical criteria of the metabolic syndrome may be helpful in identifying middle-aged individuals with clustered risk factors who may benefit from more intensive lifestyle modification and pharmacotherapy accompanied by weight loss to reduce the risk for developing CVD and diabetes. 
